PF-Atlas › Clinical Trials › NCT00004471

Phase I Pilot Study of Gene Therapy for Cystic Fibrosis Using Cationic Liposome Mediated Gene Transfer

pGT-1 gene lipid complex · Phase 1

Registry ID
NCT00004471
Phase
Phase 1
Status
Completed
Drug / intervention
pGT-1 gene lipid complex
Sponsor
University of Alabama at Birmingham
Start
1995-08
Enrollment
9

About this trial

OBJECTIVES: Determine whether copies of the cystic fibrosis gene (pGT-1) can be delivered to the cells lining the nose of cystic fibrosis patients using cationic liposome (DMRIE/DOPE) mediated gene transfer.

View NCT00004471 on ClinicalTrials.gov →

Explore related

All pGT-1 gene lipid complex trialsAll IPF trials
Medical disclaimer. This page summarizes public trial data for NCT00004471 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.